Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone versus dexamethasone for hospitalized pregnant women with COVID-19 requiring oxygen
ACTRN12621001603808Phase 3Not yet recruiting
- Sponsor
- Monash Health
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of prednisolone and dexamethasone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Monash Health. Primary endpoint: WHO ordinal scale of clinical improvement. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
prednisolonedexamethasone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ACTRN12621001603808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001603808.